Qiagen files patent infringement complaint against bioMerieux
Qiagen (QGEN) announced that it has filed a complaint against bioMerieux for patent infringement. The complaint, filed in the Local Division of ...
Business Wire10d
QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing
VENLO, The Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has filed a complaint against bioMérieux S.A. (EPA: BIM) for patent ...
Qiagen announces FDA clearance for QIAstat-Dx Gastrointestinal Panel 2 Mini B
Qiagen (QGEN) announced that the FDA has cleared the QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use. This marks Qiagen’s second ...
Benzinga.com1mon
Qiagen Stock Price, Quotes and Forecasts | NYSE:QGEN | Benzinga
Explore Qiagen stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for QGEN. 18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year ...
Nasdaq10d
QIAGEN Files Patent Complaint Against BioMérieux To Protect QuantiFERON Technology
(RTTNews) - QIAGEN N.V. (QGEN) announced that it has filed a complaint against bioMrieux S.A. for patent infringement, reinforcing its commitment to protecting the scientific advancements behind ...